Tibet Cheezheng Tibetan Medicine Co Ltd (002287) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥34.69 Million ≈ $5.08 Million USD) by net assets (CN¥4.85 Billion ≈ $710.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002287 market cap overview for the company's overall valuation and market capitalisation.

Tibet Cheezheng Tibetan Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Tibet Cheezheng Tibetan Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tibet Cheezheng Tibetan Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Cheezheng Tibetan Medicine Co Ltd ranked by their cash flow conversion efficiency. Explore Tibet Cheezheng Tibetan Medicine Co Ltd (002287) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Electro Optic Systems Holdings Ltd
AU:EOS
-0.063x
Jiangsu New Energy Development Co Ltd
SHG:603693
0.063x
Farasis Energy Gan Zhou Co Ltd
SHG:688567
0.036x
Hamburger Hafen und Logistik Aktiengesellschaft
F:HHFA
0.069x
EMTEK (Shenzhen) Co. Ltd.
SHE:300938
N/A
Peptron Inc
KQ:087010
-0.028x
Perrigo Company PLC
NYSE:PRGO
-0.045x
BGF Retail Co Ltd
KO:282330
0.188x

Annual Cash Flow Conversion Efficiency for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Tibet Cheezheng Tibetan Medicine Co Ltd from 2006 to 2025. View Tibet Cheezheng Tibetan Medicine Co Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.00 Billion
≈ $731.01 Million
CN¥729.70 Million
≈ $106.78 Million
0.146x +31.54%
2024-12-31 CN¥4.11 Billion
≈ $601.91 Million
CN¥456.75 Million
≈ $66.84 Million
0.111x -39.62%
2023-12-31 CN¥3.77 Billion
≈ $551.69 Million
CN¥693.41 Million
≈ $101.47 Million
0.184x +118.09%
2022-12-31 CN¥3.39 Billion
≈ $495.72 Million
CN¥285.69 Million
≈ $41.80 Million
0.084x -73.76%
2021-12-31 CN¥3.22 Billion
≈ $471.24 Million
CN¥1.03 Billion
≈ $151.44 Million
0.321x +254.77%
2020-12-31 CN¥2.63 Billion
≈ $385.52 Million
CN¥238.65 Million
≈ $34.92 Million
0.091x -49.53%
2019-12-31 CN¥2.26 Billion
≈ $330.99 Million
CN¥405.95 Million
≈ $59.40 Million
0.179x -26.50%
2018-12-31 CN¥2.05 Billion
≈ $299.28 Million
CN¥499.40 Million
≈ $73.08 Million
0.244x +101.20%
2017-12-31 CN¥1.89 Billion
≈ $277.12 Million
CN¥229.83 Million
≈ $33.63 Million
0.121x -45.39%
2016-12-31 CN¥1.75 Billion
≈ $256.28 Million
CN¥389.20 Million
≈ $56.95 Million
0.222x +42.32%
2015-12-31 CN¥1.65 Billion
≈ $241.61 Million
CN¥257.81 Million
≈ $37.73 Million
0.156x -22.18%
2014-12-31 CN¥1.55 Billion
≈ $226.77 Million
CN¥310.95 Million
≈ $45.50 Million
0.201x +46.41%
2013-12-31 CN¥1.45 Billion
≈ $211.92 Million
CN¥198.48 Million
≈ $29.04 Million
0.137x +9.18%
2012-12-31 CN¥1.35 Billion
≈ $197.79 Million
CN¥169.67 Million
≈ $24.83 Million
0.126x +1466.31%
2011-12-31 CN¥1.28 Billion
≈ $186.94 Million
CN¥-11.74 Million
≈ $-1.72 Million
-0.009x -111.47%
2010-12-31 CN¥1.21 Billion
≈ $176.96 Million
CN¥96.91 Million
≈ $14.18 Million
0.080x -47.76%
2009-12-31 CN¥1.14 Billion
≈ $167.50 Million
CN¥175.58 Million
≈ $25.69 Million
0.153x +23.84%
2008-12-31 CN¥532.28 Million
≈ $77.89 Million
CN¥65.93 Million
≈ $9.65 Million
0.124x -46.31%
2007-12-31 CN¥396.33 Million
≈ $58.00 Million
CN¥91.43 Million
≈ $13.38 Million
0.231x +173.63%
2006-12-31 CN¥456.61 Million
≈ $66.82 Million
CN¥38.50 Million
≈ $5.63 Million
0.084x --

About Tibet Cheezheng Tibetan Medicine Co Ltd

SHE:002287 China Biotechnology
Market Cap
$1.62 Billion
CN¥11.08 Billion CNY
Market Cap Rank
#6969 Global
#1465 in China
Share Price
CN¥19.37
Change (1 day)
+0.52%
52-Week Range
CN¥18.62 - CN¥26.86
All Time High
CN¥1299.72
About

Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculo… Read more